Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC

Clinical trial NCT06172205 · RECRUITING

Trial details

NCT number: NCT06172205
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

BCLC Stage C Hepatocellular Carcinoma Chemotherapy Effect

Start date: 2023-07-01
Primary completion: 2028-07-31
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.